6669 — Acotec Scientific Holdings Balance Sheet
0.000.00%
- HK$2.40bn
- HK$1.69bn
- CNY533.99m
- 44
- 25
- 83
- 52
Annual balance sheet for Acotec Scientific Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 147 | 1,137 | 986 | 879 | 864 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 35.5 | 49.9 | 136 | 151 | 161 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 218 | 1,244 | 1,256 | 1,211 | 1,211 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 44.8 | 56.9 | 120 | 353 | 343 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 273 | 1,307 | 1,411 | 1,611 | 1,663 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 404 | 88.1 | 98.7 | 116 | 135 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 554 | 100 | 134 | 315 | 313 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | -281 | 1,207 | 1,276 | 1,297 | 1,350 |
Total Liabilities & Shareholders' Equity | 273 | 1,307 | 1,411 | 1,611 | 1,663 |
Total Common Shares Outstanding |